Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Compass Pathways on ...
Phase 3 clinical trial data has been a success. COMP360 is the first traditional psychedelic to consistently deliver a highly statistically significant outcome. Results included maintaining a ...
Compass Pathways has reported another phase 3 win for its psilocybin therapy in treatment-resistant depression, sending the British biotech’s share price up 30% and teeing up talks about filing for ...
More than half of the $6.15 million in school voucher money spent in South Carolina last year lined the pockets of three big box retailers that sell electronics and office supplies, new data shows.
Sodexo’s GPO, Entegra, has achieved comparable scale with Compass, increasing the likelihood it can close the margin gap in the near future.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results